论文部分内容阅读
应用肝素治疗肺心病,临床疗效已肯定,我们对比观察了小剂量肝素对老年肺心病动脉血气指标及临床死亡率的影响,为肝素临床应用提供客观依据。一、资料与方法(一)观察对象:老年慢性阻塞性肺气肿,肺心病急性加重期,心功能Ⅲ级及Ⅳ级病人,共20例,随机均分为观察组及对照组,观察组平均年龄68.3岁,对照组67.3岁,性别比男:女均为9 : 1,肺心病史(年)平均为3.2及3.1。(二)治疗方法:对照组:常规综合治疗,包括休息,限盐,控制吸氧,抗感染,平喘,止咳祛痰,强心、利尿及扩血管等。观察组:常规综合治疗基础上加用肝素12500°+5%葡萄糖或生理盐水500 nl静滴4小时滴完,共10天。(三)观察内容及方法:于治疗前及治疗10天后
Application of heparin in the treatment of pulmonary heart disease, the clinical efficacy has been affirmed, we observed the effect of low-dose heparin on arterial blood gas index of elderly patients with pulmonary heart disease and clinical mortality, provide an objective basis for the clinical application of heparin. First, the data and methods (A) the observed objects: senile chronic obstructive pulmonary emphysema, acute exacerbation of pulmonary heart disease, cardiac function grade Ⅲ and Ⅳ patients, a total of 20 cases were randomly divided into observation group and control group, observation group The average age was 68.3 years, while the control group was 67.3 years old. The sex ratio was 9: 1 for both males and females, and the average history of pulmonary heart disease (years) was 3.2 and 3.1. (B) treatment: control group: conventional comprehensive treatment, including rest, salt restriction, control of oxygen, anti-infection, asthma, cough and expectorant, cardiac, diuretic and vasodilator. Observation group: conventional combined treatment based on the use of heparin 12500 ° + 5% glucose or saline 500 nl intravenous drip finished 4 hours, a total of 10 days. (C) observation content and methods: before treatment and after treatment for 10 days